Allergen-stimulated expression of CD154 (CD40 ligand) on CD3+ lymphocytes in atopic, but not in nonatopic individuals. Modulation by bacterial lipopolysaccharide

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 7, 1999, Pages 722-729

  Nakstad, Britt ^a   Kahler H ^a   Lyberg, T ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atopy; Birch pollen; CD11a; CD154; HLA DR; Interleukins; Leukocytes; Lipopolysaccharide

Indexed keywords

ALLERGEN; CD3 ANTIGEN; CD40 ANTIGEN; EOSINOPHIL CATIONIC PROTEIN; HLA DR ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; ATOPY; BACTERIAL INFECTION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0032837199     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00022.x     Document Type: Article

References (53)

1. Strachan DP. Hay fever, hygiene and household size. BMJ 1989;99:1259-1260.
2. von Mutius E, Martinez FD, Fritzch C, et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994;149:358-364.
3. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997;7:1131-1139.
4. Holt PG. Environmental factors and primary T cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995;6:1-10.
5. Holt PG. Infections and development of allergy. Toxicol Lett 1996;86:205-210.
6. Holt PG. A potential vaccine strategy for asthma and allied atopic diseases. Lancet 1994;344:456-458.
7. Noelle RJ, Roy M, Shephard DM, Stamenkovic L, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 1992;89:6550-6554.
8. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B-cell associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992;22:2573-2578.
9. Armitage RJ, Tough TW, Macduff BM, et al. CD40 ligand is a growth factor. Eur J Immunol 1993;23:2326-2331.
10. Hollenbaugh D, Grosmaire LS, Kullas CD, et al. The human T cell antigen gp39, a member of the TNF gene family, is the ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-4321.
11. Bartlett WC, Michael A, McCann J, Yuan D, Claassen E, Noelle RJ. Cognate interactions between helper T cells and B cells. II. Dissection of cognate help by using class II-restricted, antigen-specific, IL-2-dependent helper T cell clone. J Immunol 1989;143:1745-1754.
12. Klaus SJ, Pinchuk LM, Ochs HD, et al. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 1994;152:5643-5652.
13. Clark DA, Lebletter JA. How B and T cells talk to each other. Nature 1994;367:425-428.
14. Lüderitz O, Galanos C, Lehmann V, et al. Lipid A. J Infect Dis 1973;128 (suppl):S17-S29.
15. Schwartz DA, Donham KJ, Olenchock SA, et al. Determinants of longitudinal changes in spirometric function among swine confinement operators and farmers. Am J Respir Crit Care Med 1995;151:47-53.
16. Smid T, Heederik D, Houba R, Quanjer PH. Dust- and endotoxin-related respiratory effects in the animal feed industry. Am Rev Respir Dis 1992;145:1474-1479.
17. Michel O, Nagy A-M, Schroeven M, et al. Dose-response relationship to inhaled endotoxin in normal subjects. Am J Crit Care Med 1997;156:1157-1164.
18. Sandstrom T, Bjermer L, Rylander R. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respit J 1992;5:992-996.
19. Michel O, Duchateau J, Plat G, et al. Blood inflammatory response to inhaled endotoxin in normal subjects. Clin Exp Allergy 1995;25:73-79.
20. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA. Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 1996;110:263-270.
21. Brandtzæg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159:195-204.
22. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996;184:539-548.
23. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2 type cytokines at the maternal-fetal interface. J Immunol 1993;151:4562-4573.
24. Warner JA, Little SA, Pollock I, Longbottom JL, Warner JO. The influence of exposure to house dust mite, cat, pollen and fungal allergens in the home on primary sensitisation in asthma. Pediatr Allergy Immunol 1990;1:79-86.
25. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO. Is deficiency of interferon γ production by allergen triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994;24:423-430.
26. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994;15:406-411.
27. Cayabyab M, Phillips JH, Lanier LL. CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol 1994;152:1523-1531.
28. Levy F, Kristofic C, Heusser C, Brinkman V. Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int Arch Allergy Immunol 1997;112:49-58.
29. Davidsson A, Karlsson MG, Hellquist HB. Allergen-induced changes of B-cell phenotypes in patients with allergic rhinitis. Rhinology 1994;32:184-190.
30. Markert UR, Junker U, Bär C, et at. In vitro intracellular CD40 ligand expression after PHA stimulation is higher in T cells from allergic patients than from healthy probands. Allergy Clin Immunol Int 1997; (Suppl 4):135A.
31. Yellin MJ, Sippel K, Inghirami G, et al. CD40 molecules induce down-mudulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40L. J Immunol 1994;152:598-608.
32. van Kooten C, Gaillard C, Galizzi JP, Fossiez F, Banchereau J, Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through release of soluble CD40. Eur J Immunol 1994;24:787-792.
33. Ding L, Green JM, Thombson CB, Shevach EM. B7/CD28-dependent and -independent induction of CD40 ligand expression. J Immunol 1995;155:5124-5132.
34. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2497-2510.
35. Yellin MJ, Lee JJ, Chess L, Lederman S. A human CD4-T cell leukemia subclone with contact-dependent helper function. J Immunol 1991;147:3389-3395.
36. Spriggs MK, Armitage RJ, Strockbine L, et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992;176:1543-1550.
37. Heinzelmann M, Mercer-Jones MA, Gardner SA, Wilson MA, Polk HC. Bacterial cell wall products increase monocyte HLA-DR and ICAM-1 without affecting lymphocyte CD18 expression. Cell Immunol 1997;176:127-134.
38. Faas MM, Bakker WW, Valkhof N, van der Horst MC, Schuiling GA. Reproductive condition and the low-dose endotoxin-induced inflammatory response in rats. Glomerular influx of inflammatory cells and expression of adhesion molecules. Biol Reprod 1997;56:1400-1406.
39. Haugen TS, Skjønsberg OH, Nakstad B, Lyberg T. Modulation of adhesion molecule profiles on alveolar macrophages and blood monocytes. Respiration 1999 (in press).
40. Parker DCA. T cell-dependent B cell activation. Annu Rev Immunol 1993;11:331-360.
41. Hill A, Chapel H. X-linked immunodeficiency. The fruits of corporation. Nature 1993;361:494.
42. Damle NK, Klussman K, Leytze G, et al. Costimulation of T-lymphocytes with integrin ligand intercellular adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B-cells. J Immunol 1994;152:2686-2697.
43. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1998;9:195-199.
44. Noelle RJ. The role of gp (CD40L) in immunity. Clin Immunol Immunopathol 1995;76:5203-5207.
45. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-4586.
46. Jaiswal AT, Dubey C, Swain SL, Croft M. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not costimulatory signals. Int Immunol 1996;8:275-285.
47. Rylander R, Bake B, Fisher JJ, Helander IM. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989;140:981-986.
48. Michel O, Ginanni R, LeBon B, Content J, Duchateau J, Sergysels R. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis 1992;146:352-357.
49. Dubin W, Martin TR, Swoveland Å, et al. Asthma and endotoxin; lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol 1996;270:L736-744.
50. Michel O, Gianni R, Sergysels R. Characteristics of subjects defined as bronchial obstructive responders to inhaled endotoxins. Thorax 1992;47:289-292.
51. Morrisson DC, Raziuddin S. Lipopolysaccharide and endotoxin. Amsterdam: Elsevier, 1982:169-199.
52. Takanashi S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1997;180:711-715.
53. Lu P, Urban JF, Zhou XD, et al. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 1+1 response, but is not required for T-cell IL-4 production. J Immunol 1996;156:337-333.